Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell analysis of diverse immune phenotypes in malignant pleural effusion. | Nat Commun | 2021 | 34795282 | PubTator, text mining | PubMed |
| Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin. | Cell Death Dis | 2021 | 34795209 | PubTator, text mining | PubMed |
| Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome. | Front Oncol | 2021 | 34790575 | PubTator, text mining | PubMed |
| An integrative proteomics method identifies a regulator of translation during stem cell maintenance and differentiation. | Nat Commun | 2021 | 34772928 | PubTator, text mining | PubMed |
| Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review. | Cancers (Basel) | 2021 | 34771640 | PubTator, text mining | PubMed |
| The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. | Int J Mol Sci | 2021 | 34769503 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Analysis of Human Small Antral Follicles. | Int J Mol Sci | 2021 | 34769386 | PubTator, text mining | PubMed |
| Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma. | Int J Mol Sci | 2021 | 34768783 | PubTator, text mining | PubMed |
| Loss of sister kinetochore co-orientation and peri-centromeric cohesin protection after meiosis I depends on cleavage of centromeric REC8. | Dev Cell | 2021 | 34758289 | PubTator, text mining | PubMed |
| Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis. | Sci Rep | 2021 | 34750486 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. | Toxicol Appl Pharmacol | 2021 | 34742744 | PubTator, text mining | PubMed |
| Screening Hub Genes of Hepatocellular Carcinoma Based on Public Databases. | Comput Math Methods Med | 2021 | 34737790 | PubTator, text mining | PubMed |
| Single-cell RNA-seq of out-of-thaw mesenchymal stromal cells shows tissue-of-origin differences and inter-donor cell-cycle variations. | Stem Cell Res Ther | 2021 | 34736534 | PubTator, text mining | PubMed |
| CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20. | Chin Med J (Engl) | 2021 | 34732665 | PubTator, text mining | PubMed |
| [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2021 | 34728029 | PubTator, text mining | PubMed |
| Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma. | J Cell Mol Med | 2021 | 34726341 | PubTator, text mining | PubMed |
| Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity. | BMC Cancer | 2021 | 34711181 | PubTator, text mining | PubMed |
| The Cohesin Complex and Its Interplay with Non-Coding RNAs. | Noncoding RNA | 2021 | 34707078 | PubTator, text mining | PubMed |
| Age-dependent integrity of the meiotic spindle assembly checkpoint in females requires Aurora kinase B. | Aging Cell | 2021 | 34704342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=37